A deep dive into the fees of four hospitals revealed that patients are paying as much as 2,100% more than distributors for some medical products.

Mesh will stay on the market in the U.K. while the government implements near- and long-term changes to protect patient safety.

Banyan Biomarkers picked up the approval after showing the test reliably rules out intracranial lesions.

The FDA approved the use of Viz.AI’s artificial intelligence software that is designed to help quickly identify whether a patient has suffered a stroke.

Abbott, Johnson & Johnson and 22 other organizations have told the FDA which medical device regulations they think the agency should scrap or revise.

The FDA and the Nuclear Regulatory Agency have cleared the use of NorthStar Medical’s RadioGenix system to produce technetium-99m.

Smith & Nephew, a London-based medical device maker, has launched its new single-use negative pressure wound system in the European market.

Empatica picked up an FDA 510(k) clearance for Embrace after the device detected every seizure in a 135-patient clinical trial.